PINC Research is bearish on GSK Pharma and has recommended sell rating on the stock with a target price of Rs 1,822 in its November 4, 2011 research report.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!